Pebblebrook Hotel Trust has closed on the sale of the 236-room Hotel Spero in San Francisco for $71 million to an undisclosed third party.
In a news release, Pebblebrook said Hotel Spero’s net operating loss for the trailing 12 months ending June 30, 2022, was $1.6 million. The hotel's earnings before interest, taxes, depreciation and amortization was a loss of $1.4 million. Looking back to the hotel’s 2019 performance, the sale price reflects a 9.1 times EBITDA multiple and a 9.8% net operating income capitalization rate.
The net operating loss for both periods mentioned is after an assumed annual capital reserve of 4% of total hotel revenue.
Pebblebrook will use proceeds from the sale of Hotel Spero for general corporate purposes and reducing its outstanding debt borrowings from its recent hotel acquisitions.
The Hotel Spero, built in 1928, was part of the 40-hotel portfolio that Pebblebrook gained through its 2018 acquisition of fellow hotel real estate investment trust LaSalle Hotel Properties. The hotel is neighbor to the 208-room The Marker San Francisco, the hotel that Pebblebrook sold at the end of June for $77 million.
Pebblebrook has been busy this year buying and selling hotels after an active 2021. Along with the sale of The Marker, the REIT closed earlier this month on the sale of the Sofitel Philadelphia at Rittenhouse Square for $80 million.
On the acquisition side, it picked up the 257-room Gurney’s Newport Resort & Marina in Newport, Rhode Island, for $174 million in late June and the 119-room Inn on Fifth in Naples, Florida, for $156 million in May.
In 2021, the company acquired five properties for $492 million and sold three for $276.1 million.
During the second-quarter earnings call, Pebblebrook Chairman, President and CEO Jon Bortz told analysts he expects the company will be a net seller for the remainder of 2022.